SMO and diffuse large B-cell lymphoma: Interestingly, three out of four GCB primary DLBCL CNS patients had NFM mutations in PTEN. Another gene, SMO, represents an oncogene that, if mutated, leads to increased susceptibility for developing malignant disorders.